Imitrex is a brand-name prescription drug that helps to relieve migraine and cluster headaches. The active ingredient, sumatriptan succinate, belongs to a family of drugs called triptans (or 5-HT receptor agonists) and works by causing blood vessels in the head to constrict, relieving many of the symptoms of migraine or cluster headache. Imitrex can be taken as a tablet, nasal spray, or injection. All work differently, so the method prescribed will depend on each individual’s condition.
RELATED: Learn more about Imitrex | Get Imitrex discounts
Each form of Imitrex—tablets, injections, or nasal spray—varies in the amount of drug that makes it into the bloodstream. As a result, the different dosage forms have significantly different dosing strengths.
Tablets: 25 milligrams (mg), 50 mg, 100 mg
Nasal spray: 5 mg, 10 mg, 20 mg
Injection (StatDose Pen): 4 mg, 6 mg
Imitrex nasal spray is packaged in individual nasal spray units containing a single dose. Injections are packaged as injector pen cartridges each containing a single dose.
Imitrex dosage chart | ||||
---|---|---|---|---|
Indication | Form | Starting dosage | Standard dosage | Maximum dosage |
Migraine | Tablet | 25–100 mg | 25–100 mg tablet followed by a second dose if necessary no sooner than 2 hours later | 200 mg in 24 hours |
Nasal spray | 5–20 mg | 5–20 mg single nasal spray followed by a second dose if necessary no sooner than 2 hours later | 40 mg in 24 hours | |
Pen auto-injector | 4–6 mg | 4–6 mg subcutaneous injection followed by a second dose if necessary no sooner than 1 hour later | 12 mg in 24 hours | |
Cluster headache | Pen auto-injector | 4–6 mg | 4–6 mg subcutaneous injection followed by a second dose if necessary no sooner than 1 hour later | 12 mg every 24 hours |
Imitrex tablets, nasal spray, and injections are FDA approved as an acute treatment of migraine with or without aura. Migraine headaches are triggered by a variety of factors and are a complex phenomenon involving overexcitement of nerve cells and dilation of blood vessels in the head. The dilation of blood vessels causes many of the symptoms of a migraine. Sumatriptan narrows those blood vessels, thus relieving migraine symptoms.
Imitrex dosage forms vary in their effects. About 14%–17% of the sumatriptan in a tablet or nasal spray dose makes it into the bloodstream. The nasal spray, though, starts working sooner—in about 15 minutes—rather than 30–60 minutes for a tablet. On the other hand, almost all of an injection dose enters the bloodstream, begins working in minutes, and produces a much higher peak concentration than either tablets or nasal spray.
Standard dosage for migraine (tablets): 25–100 mg dose tablet followed by a seconddose if necessary no sooner than two hours later
Standard dosage for migraine (nasal spray): 5–20 mg dose followed by a second dose if necessary no sooner than two hours later
Standard dosage for migraine (injection): 4–6 mg dose followed by a second dose if necessary no sooner than one hour later
Maximum dosage for migraine (tablets): 200 mg per 24-hour period
Maximum dosage for migraine (nasal spray): 40 mg per 24-hour period
Maximum dosage for migraine (injection): 12 mg per 24-hour period
Imitrex injections are approved to treat acute cluster headaches. As with migraines, sumatriptan relieves the symptoms of cluster headache by constricting blood vessels in the head and face.
Standard dosage for cluster headache (injection): 4–6 mg dose followed by a second dose if necessary no sooner than one hour later
Maximum dosage for cluster headache (injection): 12 mg per 24-hour period
Imitrex is only approved for use in adults 18 years and older, though some healthcare professionals may use Imitrex injections off-label as an acute treatment of migraine in children.
For a variety of reasons, Imitrex may not be the right medication for some people. Contraindications include ischemic coronary artery disease, heart attack, angina pectoris, some forms of irregular heartbeat, history of stroke or transient ischemic attack (TIA), hemiplegic or basilar migraines, peripheral vascular disease, ischemic bowel disease, uncontrolled hypertension, severe liver impairment, or severe hypersensitivity to the drug. People with renal impairment, mild to moderate liver impairment, and the elderly do not require a dose adjustment but should use Imitrex with caution. Caution is also required in those with seizure disorders, high blood pressure, latex allergy (if using the injectable form), and cardiac risk factors.
Imitrex is taken as a tablet, nasal spray, or self-administered subcutaneous injection. Doses will vary between these different formats.
Read and follow the patient instructions that come with this medicine.
If you do not get any relief from the first dose, do not take a second dose without first talking to a doctor or other healthcare provider.
If you get some relief from the first dose, but the migraine returns or the first dose does not provide enough relief, wait for at least one hour (injection) or two hours (tablets or nasal spray) before taking a second dose.
If more than two doses are required in a single day, do not take additional doses. Call a doctor or other healthcare professional for medical advice.
Imitrex tablets can be taken with or without food
Swallow
Imitrex tablets whole with a glass of water or other liquid
The Imitrex nasal spray unit delivers a single dose
Imitrex nasal spray is administered into one nostril only
Before using, blow your nose to clear the nasal passages.
Insert the nozzle into the open nostril and close your mouth.
Press the blue plunger while breathing in through the open nostril.
Remove the nozzle and, facing forward, gently breathe in through the nose and out through the mouth for 10–20 seconds.
The STATdose pen injects a single dose of Imitrex
A healthcare professional will demonstrate how to use the STATdose cartridges and pen injector
The STATdose injector comes in a carrying case for both the pen injector and medicine cartridges
The carrying case contains only two doses. Do not use more than one carrying case (two doses) per day
Have a healthcare professional demonstrate the correct injection technique before taking the first dose.
Carefully follow the instructions on the package insert.
Properly dispose of used cartridge packs.
Imitrex injections will begin to work in about six minutes and the medicine reaches its peak concentration in the blood in about 12 minutes. In contrast, Imitrex nasal spray begins working in about 15 minutes while the tablet takes about 30 minutes with a peak concentration in about 45 minutes. However, migraine-induced gastroparesis (delayed gastric emptying) could delay the tablet’s effectiveness by another 30 minutes.
With a half-life of close to two hours, Imitrex is short-acting and quickly cleared from the body. Some people experience a return of migraine symptoms when the first dose wears off, so a second dose may be needed.
Imitrex is usually taken at the onset of migraine or cluster headache symptoms but can be administered at any time during a cluster headache or migraine attack. A second dose can be administered after two hours if symptoms only partially resolve or the headache returns. Do not take a second dose if the first dose provides no noticeable relief and contact a healthcare provider.
Used as directed, Imitrex can be safely discontinued without problems. However, using Imitrex too frequently—10 or more days a month—can cause medication-overuse headache (MOH), a condition in which the frequency and intensity of headaches increases when using too much headache medication. Fortunately, stopping sumatriptan does not cause withdrawal symptoms other than rebound headache and possibly nausea or sleep problems. These fade in about four days. A doctor may choose to stop the medication completely or use a steadily decreasing dose.
In addition to medical-overuse headache, a healthcare professional may choose to end sumatriptan treatment at any sign of heart problems, such as chest pain (angina), chest tightness, or shortness of breath. Imitrex will also be discontinued in case of stroke, transient ischemic attack, or a severe allergic reaction. If sumatriptan is discontinued, alternative therapies include other triptans, ergot drugs, pain relievers, CGRP antagonists, anti-nausea drugs, dexamethasone, or a range of physical treatments.
Other side effects of Imitrex can include nausea, dizziness, drowsiness, vomiting, spinning sensation, and sensitivity to light or sound. If you experience any of these side effects after taking Imitrex, contact your healthcare professional.
The maximum daily dose for Imitrex is two 100 mg tablets, two 12 mg nasal sprays, or two 6 mg injections. Healthcare professionals will warn people not to take Imitrex 10 or more days per month.
Some Imitrex drug interactions can cause serious side effects including serotonin syndrome, vasospasms, or dangerously high blood pressure.
Imitrex should not be used within two weeks of taking an MAO inhibitor such as Marplan (isocarboxazid), phenelzine, tranylcypromine, selegiline, linezolid, or procarbazine.
Imitrex should not be taken within 24 hours taking other triptans such as Amerge (naratriptan), Axert (almotriptan), rizatriptan, or Treximet (sumatriptan and naproxen), or ergot migraine drugs such as ergotamine and dihydroergotamine.
Serotonin syndrome, a neurological condition caused by excess serotonin in the brain, is also a risk when Imitrex is taken with antidepressants, particularly SSRIs (such as fluoxetine) and SNRIs (such as venlafaxine).
The safety of taking Imitrex while pregnant has not been definitively established. Clinical studies, however, have not shown an increase in birth defects in pregnant mothers taking sumatriptan. Nursing mothers are cautioned to avoid breastfeeding for 12 hours after taking a sumatriptan dose. Sumatriptan does pass into breast milk when taken during lactation. Before starting Imitrex, inform your healthcare provider if you are pregnant, may become pregnant, or are breastfeeding.
Anne Jacobson, MD, MPH, is a board-certified family physician, writer, editor, teacher, and consultant. She is a graduate of University of Wisconsin School of Medicine and Public Health, and trained at West Suburban Family Medicine in Oak Park, Illinois. She later completed a fellowship in community medicine at PCC Community Wellness and a master's in Public Health at the University of Illinois-Chicago. She lives with her family near Chicago.
...Health education, drug info, wellness & more
(Except Major Holidays)
© 2024 SingleCare Administrators. All Rights Reserved.
* Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price.
Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
This is a prescription discount plan. This is NOT insurance nor a Medicare prescription drug plan. The range of prescription discounts provided under this discount plan will vary depending on the prescription and pharmacy where the prescription is purchased and can be up to 80% off the cash price. You are fully responsible for paying your prescriptions at the pharmacy at the time of service, but you will be entitled to receive a discount from the pharmacy in accordance with the specific pre-negotiated discounted rate schedule. Towers Administrators LLC (operating as 'SingleCare Administrators') is the authorized prescription discount plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services LLC ('SingleCare') is the vendor of the prescription discount plan, including their website.website at www.singlecare.com. For additional information, including an up-to-date list of pharmacies, or assistance with any problems related to this prescription drug discount plan, please contact customer service toll free at 844-234-3057, 24 hours a day, 7 days a week (except major holidays). By using the SingleCare prescription discount card or app, you agree to the SingleCare Terms and Conditions found at https://www.singlecare.com/terms-and-conditions